Abstract: A tool of an interventional medical systems system includes a core configured to be temporarily attached to the implantable medical device, as the tool deploys the device to expose a fixation member of the device for engagement with tissue at a target implant site; the core is then employed to verify adequate fixation of the deployed device via a tug test. An operator determines that the device is adequately fixed by the engaged fixation member, if a tug force that is applied to the core modifies the temporary attachment between the core and the device, to allow release of the device from the temporary attachment. A tether, which is fixedly attached to the core, may be employed to create the temporary attachment between the core and the device, or the temporary attachment may be created by a snap fit formed between the core and the attachment structure of the device.
Type:
Grant
Filed:
April 1, 2014
Date of Patent:
March 15, 2016
Assignee:
Medtronic, Inc.
Inventors:
William A. Berthiaume, Don H. Tran, Brent L. Locsin, Maria E. Valdovinos, H. Allan Steingisser, Erik Griswold
Abstract: The invention describes a method and compositions where the presence of cobalt and or nickel have been depleted from the surface layer(s) of a cobalt, chromium, nickel containing alloy.
Abstract: An implantable active medical device includes a hermetic housing defining an exterior surface and a hermetic cavity of an implantable active medical device. The hermetic housing has a first major surface, an opposing second major surface and a side surface extending between them. An elongate lead connector is recessed into the first major surface. The elongate lead connector has a top surface and a bottom surface and a side surface extending between them. The top surface forms only a portion of the first major surface.
Abstract: A method of a forming a hollow, drug-eluting medical device includes providing composite member having an outer member and a core member disposed within a lumen of the outer member. The composite member is shaped into a pattern. Openings are formed through the outer member of the composite member. The composite member is processed to remove the core member from the lumen of the outer member without harming the outer member, leaving a hollow tubular member already formed into the desired pattern. The lumen of the outer member is filled with a therapeutic substance.
Type:
Grant
Filed:
July 9, 2009
Date of Patent:
March 15, 2016
Assignee:
Medtronic Vascular, Inc.
Inventors:
Matthew J. Birdsall, Christopher Storment, D. H. Perkins, Dustin Thompson
Abstract: A method for determining an applicable path of movement of an object in human or animal tissue is based on intensity data obtained by a 3D imaging technique. The applicable path of movement connects a starling position of the object with a defined target location. The method includes defining the target location of a reference point of the object and choosing at least one possible starting position of the reference point of the object. Further, the method includes determining a candidate path of movement between the corresponding possible starling position and the defined target location. Next, the candidate path of movement is evaluated for being an applicable path. The candidate path is evaluated based on information about local intensity extrema and/or intensity variation resulting from the intensity data along the candidate path of movement.
Type:
Grant
Filed:
January 13, 2012
Date of Patent:
March 15, 2016
Assignee:
Medtronic Bakken Research Center B.V.
Inventors:
Ahmet Ekin, Hubert Cecile Francois Martens
Abstract: An annuloplasty ring including a sheath, an arcuate stiffening element, and a tensioning member. The stiffening element is disposed within the sheath and defines discrete, first and second ends separated by a lateral spacing. The tensioning member extends between the stiffening element ends. The tensioning member is characterized as being more flexible than the stiffening element and is configured to provide a taut state in which the tensioning member is substantially non-extensible and impedes expansion of the lateral spacing. With this configuration, the stiffening element serves to remodel the valve annulus to a desired shape, while the tensioning member exhibits sufficient flexibility to allow for natural movement of the valve annulus while limiting (in the taut state) the extent of annular dilatation (e.g., overt lateral separation of the first and second ends of the stiffening member) due to in vivo forces.
Type:
Grant
Filed:
May 31, 2007
Date of Patent:
March 15, 2016
Assignee:
Medtronic, Inc.
Inventors:
Timothy R. Ryan, Cathleen A. Bergin, Jerald Redmond
Abstract: A tine portion of an implantable medical device includes a hook segment and a distal segment extending therefrom, wherein the hook segment is pre-set to extend along a curvature and is elastically deformable therefrom to an open position. The distal segment includes a tooth and an end that surrounds the tooth, wherein the end includes a pair of legs and a distal arch. The legs extend along a length of, and on opposing sides of the tooth, and the distal arch extends between the legs, distal to a tissue-piercing tip of the tooth. When the hook segment is in the open position, and a force is applied along a longitudinal axis of the device, to push the distal arch of the distal segment against tissue, for initial tissue penetration, the legs of the end of the distal segment bend in elastic deformation to expose the tissue-piercing tip to the tissue.
Type:
Grant
Filed:
September 15, 2015
Date of Patent:
March 15, 2016
Assignee:
Medtronic, Inc.
Inventors:
Vladimir Grubac, Jonathan L Kuhn, Kenneth D Rys, Richard W Swenson
Abstract: A delivery device includes a durable housing portion and a separable disposable portion that selectively engage and disengage from each other. The disposable housing portion secures to the patient and may be disposed of after it has been in use for a prescribed period. Components that normally come into contact with a patient or with infusion media are supported by the disposable housing portion for disposal after the prescribed use, while the durable housing portion supports other components such as electronics for controlling delivery of infusion media from the reservoir and a drive device and drive linkage.
Type:
Application
Filed:
October 2, 2015
Publication date:
March 10, 2016
Applicant:
Medtronic MiniMed, Inc.
Inventors:
Sheldon B. Moberg, Ian B. Hanson, Paul S. Cheney, II
Abstract: An implantable medical device system detects and treats monomorphic ventricular tachycardia (VT). The system includes a sensing module for receiving a cardiac signal and a therapy delivery module including a capacitor and an output circuit. A control module is coupled to the sensing module and the therapy delivery module and is configured to detect a tachycardia from the cardiac signal and initiate charging of the capacitor in response to detecting the tachycardia. The control module performs a method for simultaneously monitoring a voltage on the capacitor and a morphology of the cardiac signal during the charging and controls the therapy delivery circuit to deliver a shock pulse at less than a programmed shock energy in response to both the voltage reaching at least a minimum voltage and the morphology being monomorphic.
Abstract: A medical device lead connector includes two or more electrically conducting contact rings spaced apart by electrically insulating ceramic ring. An electrically insulating glass material fixes the two or more electrically conducting contact rings to the insulating ceramic ring in axial alignment.
Type:
Grant
Filed:
May 5, 2014
Date of Patent:
March 8, 2016
Assignee:
Medtronic, Inc.
Inventors:
John E. Kast, Darren A. Janzig, Christopher J. Paidosh, Andrew J. Thom, Brad C. Tischendorf, Gerald G. Lindner
Abstract: An implantable pacemaker detects delivery of an anti-tachyarrhythmia shock by another device. The implantable pacemaker delivers cardiac stimulation therapy within a patient. The implantable pacemaker senses, via the electrode pair, an electrical signal. The implantable pacemaker detects the anti-tachyarrhythmia shock based on the sensed electrical signal by detecting DC voltage polarization across the electrode pair within the patient. The implantable pacemaker alters the cardiac stimulation therapy based on the detected anti-tachyarrhythmia shock.
Type:
Grant
Filed:
January 23, 2015
Date of Patent:
March 8, 2016
Assignee:
Medtronic, Inc.
Inventors:
James D. Reinke, Glenn M. Roline, Shohan T. Hossain, Michael W. Heinks
Abstract: A system, for use in determining a volume in a reservoir, includes a bulkhead, a plunger assembly, and a base. The plunger assembly is connected to the bulkhead. The plunger assembly includes a first plunger and a second plunger. The first plunger has a corresponding first biasing member. The second plunger has a corresponding second biasing member. The base of the reservoir is connected to the first plunger. Movement of the base causes compression or expansion of the first biasing member, which causes compression or expansion of the second biasing member. The bulkhead, the first plunger, and the base define a first portion of the reservoir. Positions of the first plunger and the base, relative to the bulkhead, are based on the volume in the reservoir.
Abstract: The present invention relates to a catheter (1?, 1?) for intraluminal treatment which comprises a main tubular body (2) extending along a longitudinal axis (X) between a proximal end portion (2?) and a distal end portion (2?), which delimits at least one central lumen (4). The main tubular body identifies at least one balloon (8). The catheter further comprises at least one inner tubular body (6), at least partially housed in the central lumen, which delimits at least one inner lumen (16) for housing at least one guide wire, the portion of distal extremity of the balloon being joined to the inner tubular body. Furthermore, the central axis (Y) of the inner lumen is arched or undulated to form an accumulation of material for the expansion of the balloon. The present invention further refers to a method of manufacturing the catheter of the invention and to a machine for the production of a tool used during the aforesaid method.
Abstract: A medical device system performs a method for determining presence of scar tissue through an implanted lead having an electrode for cardiac pacing and sensing. A sensing module senses heart activity with the electrode to produce a unipolar electrogram (EGM) waveform. A processor receives the unipolar EGM waveform and extracts two or more features representative of heart activity at the electrode. Scar tissue is identified at the site of the first electrode based upon at least two of the extracted features indicating scar tissue.
Abstract: A system and method control a pacing parameter in a closed-loop manner by determining a value of an EGM-based index corresponding an optimal electrical activation condition of a patient's heart and adjusting a pacing therapy to maintain the EGM-based index value. The closed loop control method performed by the system may establish a relationship between an EGM-based index and multiple settings of a pacing control parameter. Values of the EGM-based index are stored with corresponding setting shifts relative to a previously established optimal setting. A processor of an implantable medical device monitors the EGM-based index during cardiac pacing. Responsive to detecting an EGM-based index value corresponding to a non-optimal setting of the control parameter, the processor determines an adjustment of the control parameter from the stored index values and corresponding setting shifts.
Abstract: Disclosed herein is a fluid infusion device of the type that delivers medication fluid to the body of a patient. The device includes or cooperates with a fluid reservoir, and the device has a sealing assembly to receive and form a fluid seal with the fluid reservoir. A retractable sealing element surrounding a hollow fluid delivery needle may be used to seal a port of the fluid reservoir. The port may include a pressure vent that is sealed by the retractable sealing element. In one variation, the reservoir includes a moving valve sleeve that holds a septum. The septum moves to allow the reservoir to vent, and to form a seal with the port when the needle pierces the septum. In another variation, the device includes a needleless sealing assembly. In yet other variations, the device uses a needled fluid reservoir.
Type:
Grant
Filed:
February 17, 2012
Date of Patent:
March 1, 2016
Assignee:
Medtronic MiniMed, Inc.
Inventors:
Edgardo C. Halili, Eric M. Lorenzen, Matthew William Yavorsky
Abstract: A system and method select a pacing site for a cardiac pacing therapy. A change from a baseline mechanical activity is extracted from a signal of mechanical heart activity during pacing at each one of multiple pacing sites along a heart chamber. A change from a baseline electrical activity is extracted from a signal of electrical heart activity during pacing at each of the of pacing sites. The pacing sites are sorted in a first order based upon the changes in mechanical heart activity and in a second order based upon the changes in electrical heart activity. A pacing site is selected from the multiple pacing sites as a common pacing site between the first order and the second order.
Abstract: A suturing device includes a handle, an elongated body, at least one suture snag, at least one pair of needles, and at least one suture pair. The suture snag is moveable between a deployed position in which two distal arm portions thereof radially extend away from the elongated body and a retracted position in which the two distal arm portions are disposed within the elongated body. The suture pair is slidingly disposed through the needle pair. The suturing device deploys the suture snag within a vessel adjacent to an arteriotomy, extends the needle pair through a vessel wall around the arteriotomy and through the deployed suture snag, extends the suture pair beyond the distal ends of the needle pair, and then utilizes the suture snag to capture the extended suture pair by retracting the suture snag to pull first or distal ends of the sutures back into the suturing device. An inflatable balloon or an expandable suture capture component may be alternatives to the suture snag for capturing the suture ends.
Abstract: Methods and kits are provided for determining which single nucleotide polymorphism (“SNP”) variant of an allele of a heterozygous patient is on the same allele as a disease-causing mutation that is at a remote region of the gene's mRNA comprising a) an allele specific reverse transcription reaction using an allele specific primer which recognizes one SNP variant, wherein further the 3? end of the primer is positioned at the SNP nucleotide position, and b) analysis of the resulting cDNA product from the reverse transcription reaction at the region of the mutation to determine the presence or absence of the mutation on this allele specific cDNA product, wherein the allele specific primer is shorter than about 20 nucleotides.
Type:
Grant
Filed:
May 23, 2007
Date of Patent:
March 1, 2016
Assignee:
Medtronic, Inc.
Inventors:
Paul van Bilsen, William F. Kaemmerer, Eric Burright